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Background. The effectiveness of rotavirus vaccines will be dependent on the immunity conferred against
prevalent and emergent variants causing severe diarrheal disease. Longitudinal surveillance of disease-causing strains
is a prerequisite to intervention.
Methods. Molecular characterization was conducted on rotavirus-positive stool samples from children admitted
with diarrhea to a rural district hospital during 2002–2004. Extracted viral RNA was separated by polyacrylamide
gel electrophoresis, and rotavirus VP4 (P types) and VP7 (G types) specificities were determined.
Results. Among 558 investigated cases, the predominant genotype was P[8]G1 (42%), followed by P[8]G9
(15%), P[4]G8 (7%), P[6]G8 (6%), and P[8]G8 (4%), with 10% mixed strains. Overall, there were 6 different P
types and 7 G types. No association was identified between genotype and child age, sex, or severity of diarrhea.
The P and G genotypes and polyacrylamide gel electropherotypes showed significant temporal variation in fre-
quency: P[8]G1 decreased from 51% (95% confidence interval [CI], 43%–58%) in 2002 to 30% (95% CI, 24%–
37%) in 2004, and P[4]G8 increased from 2% (95% CI, 0%–5%) in 2002 to 13% (95% CI, 9%–19%). Quarterly
data revealed seasonally endemic and emergence and/or decay patterns.
Conclusions. Our study of rotavirus strains causing severe diarrhea in rural Kenyan children showed a pre-
dominance of P[8]G1 and confirms the importance of G8 and G9 strains in sub-Saharan Africa. Considerable
genetic diversity of rotavirus strains was observed, including substantial mixed and unusual types, coupled with
significant temporal strain variation and emergence. These results warn of variable vaccine efficacy and the need
for long-term surveillance of circulating rotavirus genotypes.
Rotavirus is the leading cause of acute severe diarrhea
in children !5 years of age and is estimated to be a
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major cause of childhood death in the developing
world, in particular, the Indian subcontinent and sub-
Saharan Africa [1, 2]. Group A rotavirus strains, which
account for the vast majority of human disease, are
classified into different P and G types on the basis of
the 2 immunodominant outer capsid proteins, VP4 and
VP7, respectively. A total of 28 P types and 20 G types
[3–6] have been identified worldwide, with P[8]G1,
P[8]G3, P[8]G4, P[4]G2, P[8]G9, and P[6]G9 fre-
quently detected in annual epidemics [7].
Studies have shown wide geographical variation in
the prevalence of G and P types across continents and
local and global temporal changes in the frequency of
dominant strains and emergence of unusual P and G
types and combinations [7]. Globally, 85% of rotavirus
strains studied carry P[8]G1, P[4]G2, P[8]G3, or
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P[8]G4 specificity. However, in South America, the proportion
of the common genotypes is 68%, and in Africa, only 50% of
strains belong to one of these genotypes. Furthermore, studies
in Africa show only 23% of strains with P[8]G1 (compared
with 65% worldwide) and significant proportions of P[6], G8,
unusual, and mixed infections [7–15].
During the past 15 years, G9 strains have emerged as an
important disease-causing variant, and recently, genotype G12
strains have also emerged globally in a manner similar to the
emergence of G9 strains in the early 1990s [7]. In Africa, both
of these genotypes have been detected, and G9 strains have
been shown to predominate in certain settings, replacing the
more traditional genotypes for 1–2 seasons or circulating at
low background levels over a number of seasons. In addition,
the G9 genotype has been found in combination with P[6] or
P[8] VP4 specificity, subgroup I or subgroup II VP6 specificity,
and either long or short electropherotypes, suggesting a pro-
miscuous nature and a predilection for reassortment [16, 17].
Assessment of the impact of a rotavirus vaccine should take
into account the natural temporal variability in P and G types.
The compositions of the 2 live oral rotavirus vaccines, Rotarix
(GlaxoSmithKline) and RotaTeq (Merck), present very different
immunization strategies, with the former based primarily on
heterotypic immunity and the latter based more on homotypic
immunity [18, 19]. Although both have demonstrated safety
and proved to be efficacious in various developed and devel-
oping countries, vaccine effectiveness after implementation will
have to be closely monitored. In this way, any influence on
vaccine efficacy by the emergence and temporal increase in the
frequency of new variants, both naturally occurring and in-
duced through the process of genotype replacement, can be
determined. Longitudinal genetic surveillance of disease-caus-
ing rotavirus strains is a clear priority, particularly in Africa
before and after wide-scale vaccine introduction.
MATERIALS AND METHODS
Study samples. The present study used rotavirus-positive
stool samples from surveillance of pediatric (age, 0–12 years)
patients admitted to Kilifi District Hospital in coastal Kenya
from the period January 2002 through December 2004 [20].
Of 2039 patients with diarrhea and 620 control subjects without
diarrhea, 588 (29%) and 19 (3%), respectively, were group A
rotavirus antigen positive, as determined by enzyme immu-
noassay (DAKO Rotavirus IDEIA; Oxoid). Contemporaneous
control subjects were selected from children admitted without
a history of diarrhea frequency matched by age to patients at
a ratio of 1:3. Samples were stored unprocessed at80C before
being shipped on dry ice to the Medical Research Council–
Diarrhoeal Pathogens Research Unit, South Africa, for further
analysis. The present study performed molecular characteri-
zation of 558 (95%) and 12 (63%) group A rotavirus isolates
obtained from patients with or without severe diarrhea,
respectively.
Life-threatening diarrhea was assigned to a case with 1 of
the following clinical features: hypoxia (!90% saturation), pros-
tration or coma, hyponatremia, hypoglycemia, severe mal-
nourishment, or bacteremia. Full details of the sampling and
testing procedures, clinical definitions, and the sociodemo-
graphic, clinical, and laboratory characteristics of the children
are reported elsewhere [20]. The Kenyan National Research
Ethical Committee and the Coventry Research Ethics Com-
mittee, United Kingdom, granted ethical approval for the study.
Polyacrylamide gel electrophoresis (PAGE). The double-
stranded RNA (dsRNA) genome was extracted from 10% fecal
suspensions with use of the standard phenol-chloroform
method, followed by ethanol precipitation in the presence of
0.3 mol/L sodium acetate. The extracted RNA was resolved on
10% polyacrylamide gels with 3% stacking gels with use of a
discontinuous buffer system at 100 V for 18 h at ambient
temperature [21]. RNA segments were then stained by silver
nitrate according to published methods [22].
Viral RNA extraction for reverse-transcription polymerase
chain reaction (RT-PCR). Viral dsRNA was extracted from
250 mL of rotavirus-positive fecal suspensions with use of Tri-
Reagents-LS (Molecular Research Centre) according to the
manufacturers’ instructions. The extracted dsRNA was further
precipitated in ice-cold isopropyl alcohol, and the air-dried
pellet was resuspended in 40 mL of deionized water.
RT-PCR. The extracted dsRNA was subjected to RT-PCR
using several primer pairs taken from highly conserved regions
of the RNA genome. The primer pair sBeg/End9 was used to
generate full-length copies of the VP7 gene (1062 base pairs
[bp]), and 9con1/EndA was used to generate 903 bp of VP7
gene fragments in specimens that were difficult to type [23–
25]. Con2/Con3 and VP4F/VP4R primer pairs were used to
amplify VP4 gene fragments of the 876 bp and 663 bp, re-
spectively [26, 27]
Rotavirus typing. Genotyping of the cDNA was performed
by nested multiplex PCR using type-specific VP7 and VP4
primers described elsewhere [10, 23, 25, 26, 28–30]. The non-
typeable G and P genotypes were further analyzed using the
animal G and P primers described by Gouvea et al [31, 32].
Combinations of P and G genotypes have been defined as usual
or unusual on the basis of delineations described by Santos
and Hoshino [7].
Statistical analysis. Data were analyzed using Stata, version
10.1 (Statacorp). Exact 95% confidence intervals were defined
for genotype frequencies. The x2 test was used to test for lack
of independence in cross-tabulations (ie, for possible associa-
tion between 2 variables), pooling marginal totals of !15%, and
the Wilcoxon rank-sum test was used for equality of
distributions.
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Table 2. P and G Combinations for 558 Group A Rotavirus-
Positive Pediatric Diarrhea Cases at Kilifii District Hospital,
Kenya, 2002–2004
Type
No. (%) of cases
2002
(n p 178)
2003
(n p 169)
2004
(n p 211)
Total
(n p 558)
Usual
P[4]G2x 1 (1) 4 (2) 0 (0) 5 (1)
P[6]G1 3 (2) 0 (0) 6 (3) 9 (2)
P[6]G9xq 3 (2) 4 (2) 5 (2) 12 (2)
P[8]G1 90 (51) 79 (47) 63 (30) 232 (42)
P[8]G9 23 (13) 36 (21) 25 (12) 84 (15)
Subtotal 120 (67) 123 (73) 99 (47) 342 (61)
Unusual
P[4]G1 0 (0) 0 (0) 10 (5) 10 (2)
P[4]G8xq 3 (2) 7 (4) 28 (13) 38 (7)
P[4]G9xq 0 (0) 2 (1) 1 (0) 3 (1)
P[6]G8xq 17 (10) 1 (1) 15 (7) 33 (6)
P[8]G2 4 (2) 1 (1) 1 (0) 6 (1)
P[8]G8 8 (4) 1 (1) 13 (6) 22 (4)
Subtotal 32 (18) 12 (7) 68 (32) 112 (20)
NT or mixed
P[4]GNTxq 0 (0) 0 (0) 6 (3) 6 (1)
P[6]GNTxq 2 (1) 0 (0) 3 (1) 5 (1)
P[8]GNT 8 (4) 0 (0) 1 (0) 9 (2)
P[NT]G1 5 (3) 5 (3) 2 (1) 12 (2)
P[NT]G8xq 1 (1) 1 (1) 1 (0) 3 (1)
P[NT]G9xq 2 (1) 2 (1) 2 (1) 6 (1)
P[NT]GNT 1 (1) 2 (1) 3 (1) 6 (1)
Mixed 7 (4) 24 (14) 26 (12) 57 (10)
Subtotal 26 (15) 34 (20) 44 (21) 104 (19)
NOTE. NT, nontypeable.
Table 1. Rotavirus Polyacrylamide Gel Electro-
phoresis (PAGE) Types in 558 Pediatric Diarrhea
Cases at Kilifi District Hospital, Kenya, 2002–2004
The table is available in its entirety in the
online edition of the Journal of Infectious Diseases
RESULTS
Among 558 group A rotavirus–positive diarrhea cases (median
patient age, 10 months [interquartile range, 7–15 months]; 60%
male), 82 were PAGE negative, 26 were G nontypeable, 30 were
P nontypeable (including 6 both G nontypeable and P non-
typeable), and 508 were positive for G and P types. Of 12 group
A rotavirus-positive nondiarrhea cases in control subjects (me-
dian age, 25 months [interquartile range, 2–39 months]; 42%
male), 2 were negative for PAGE and P type.
PAGE distribution in diarrhea cases. Of 476 rotavirus
strains, 86 (18%) and 390 (82%) displayed short and long
electropherotypes, respectively (Table 1, which appears only in
the electronic version of the Journal). Three long electropher-
otypes (L1, L2, and L3) were detected in 63%, 11%, and 4.4%
of cases, respectively, and short electropherotypes (S3, S2, and
S1) were identified in 8%, 4.6%, and 3.6% of cases. The re-
mainder of the electropherotypes detected (L4–6, mixed, and
S4) had prevalences of !2%. There was evidence of temporal
variation in the PAGE composition among the 3 years, in par-
ticular, L1 and L2 and S3 types (x2(10), 123.681; ) (TableP ! .001
1, which appears only in the electronic version of the Journal).
The proportion of PAGE-negative strains did not change by
year (x2(2), 3.493; ).Pp .174
Genotype distribution in diarrhea cases. Among the 558
cases analyzed for both VP4 (P) and VP7 (G) genes, 6 different
P types and 7 G types were identified in both single and mixed
infections (Tables 2 and 3). Among the P types, P[8] was pre-
dominant (68% of all samples), followed by P[6] and P[4]
(both 12%); the other types (P[9], P[11], and P[14]) had a
low prevalence and were present in only mixed infections (Table
3). Among the G types, G1 predominated (48%), followed by
G9 (19%) and G8 (18%); the remainder (G2, G3, G4, and G10)
had a low prevalence, and G3, G4, and G10 were present as
only mixed infections (Table 3).
The predominant P-G genotype was P[8]G1 (detected in
42% of cases), followed by P[8]G9 (15%), P[4]G8 (7%),
P[6]G8 (7%), and P[8]G8 (4%). Usual and unusual genotype
combinations were identified in 61% and 20% of isolates, re-
spectively, or if excluding mixed isolates, in 68% and 25%,
respectively (Table 2). The remaining single genotypes occurred
at low frequency. Mixed infections occurred in 57 cases (10%),
with 56% of these involving P[8] and 32% including P[8] in
combination with G1 (Table 2). Specimens untypeable for at
least 1 of VP4 or VP7 genes occurred with a frequency of 9%
(Table 2).
Genotype association with age, sex, or disease sever-
ity. Data on genotypes with cases numbering !10%–15%
were pooled for analysis. In a comparison of 350 infants (age,
!1 year) with 208 children (age, 1–5 years), there was no sig-
nificant difference in the distribution of genotypes (x2(6), 3.745;
). Similarly, the distribution of genotypes in 334 malePp .711
individuals, compared with 224 female individuals, did not
significantly differ (x2(6), 5.992; ). There was no as-Pp .424
sociation between genotype and presence ( ) or absencenp 119
( ) of life-threatening diarrhea (x2(6), 4.453; ).np 439 Pp .616
Temporal variation in genotype distribution. The distri-
bution of rotavirus genotypes by year is shown in Tables 2 and
3. After pooling low-frequency observations (!15 cases over
the 3 years), there was evidence for significant temporal vari-
ation in P-G genotype composition (x2(12), 72.841; ); inP ! .001
particular, there was an increase in P[4]G8 from 2% in 2002
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Table 3. P-G Type Combinations in 57 Mixed Infections in Pe-
diatric Patients with Diarrhea at Kilifii District Hospital, Kenya,
2002–2004
P-G type
No. of infections
2002 2003 2004
P[4]G1,8 0 1 2
P[4]G1,9 0 1 1
P[4]G1,10 0 1 0
P[4]G8,9 0 0 1
P[4,6]G8 0 0 2
P[4,8]G1 1 0 0
P[4,11]G4 0 0 1
P[4,11]G8 0 1 0
P[4,14]G2 1 0 0
P[6]G1,2 0 0 1
P[6]G1,8 0 1 1
P[6]G1,9 0 1 1
P[6]G8,9 0 0 1
P[6,8]G1 0 1 0
P[6,8]G9 0 0 2
P[6,8]G1,8 0 1 0
P[6,8]G2,8,3 0 1 0
P[6,8,9]G9 0 0 1
P[9]G1 0 0 1
P[8]G1,2 1 1 0
P[8]G1,8 0 9 9
P[8]G1,9 2 2 1
P[8]G8,9 0 2 0
P[8,9]G1 1 0 0
P[NT]G1,8 0 1 1
P[NT]G1,9 1 0 0
Total 7 24 26
NOTE. NT, nontypeable.
Figure 1. Variation by year (2002–2004) in P-G genotype frequencies
(with exact 95% confidence intervals) determined for 558 rotavirus-pos-
itive samples from Kilifi District Hospital, Kenya. Low-frequency types
include all single-strain genotypes with a frequency over the 3 years of
!15 cases.
to 13% in 2004 and a decrease in P[8]G1 from 51% in 2002
to 30% in 2004 (Figure 1). Other genotypes (eg, P[6]G8)
showed significant fluctuation. Genotype observations stratified
by year and quarter (Figure 2) provide further detail of the
temporal variation, including seasonal patterns (P[8]G1),
emergence (P[4]G8), and decay and reemergence (P[6]G8).
The diversity of single genotype infections was roughly constant
at 9 different genotypes during 2002–2003 and 10 genotypes
in 2004 (Table 2). However, as shown in Figures 2 and 3 (which
appears only in the electronic version of the Journal), there was
a decrease in the dominance of one (primarily P[8]G1) or a
few genotypes coupled with altered seasonality in total diarrhea
admissions and rotavirus cases during 2004, compared with
2002–2003.
During 2004, an increase in G8 strains in combination with
P[4], P[6], and P[8] was noted (Table 2). Investigation of mixed
infections during 2003 provided possible evidence for human-
human reassortment events, because P[6]P[8]G1G8,
P[6]P[8]G2G8G3, and P[4]P[6]G8 infections were detected. In
addition, the increase in P[4]G1 infections in 2004 may have
resulted from mixed infections with G8, G9, and G10 in 2003.
Additional analysis of the full genomes of unusual human-
human reassortants and investigation of the population of ro-
tavirus strains causing mixed infections will be required.
Control subjects. Among the 12 cases in positive control
subjects with genetic results, 7 were L1; 3 were L2; 4 were
P[8]G1, 2 P[8]G9, and 2 P[nontypeable]G1; and 4 were mixed
(3 P[8]G1,9 and 1 P[8]G8,9)—approximately corresponding
to the distribution in cases. The asymptomatic control subjects
were noticeably older than the symptomatic patients (age, 25
months vs 10 months).
Vaccine type prevalence. Of 558 cases, 432 (77%) and 439
(79%) had types in common with those in the Rotarix (P[8]G1)
and RotaTeq (P[5]G1–4 and P[8]G6) vaccines, respectively. The
proportions not represented in Rotarix were 29 (16%) of 178,
20 (12%) of 169, and 70 (33%) of 211 during 2002, 2003, and
2004, respectively (x2(2), 24.291; ). Correspondingly, theP ! .001
proportions not represented in RotaTeq were 31 (17%) of 178,
24 (14%) of 169, and 71 (34%) of 211 (x2(2), 29.420; ).P ! .001
DISCUSSION
We investigated the genetic characteristics of group A rotavirus
strains in clinically well-defined severe pediatric diarrhea cases
in a rural Kenyan setting over a 3-year period. The study re-
vealed no evidence of an association between genotype and age,
sex, or disease severity. However, we identified considerable
genotypic diversity, with patterns of prevalence both consistent
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Figure 2. Seasonal variation in P-G genotypes determined for 558 group A rotavirus (GARV)–positive samples from Kilifi District Hospital, Kenya
(2002–2004). The top left panel details totals for all variants by year and quarter (bars) and total cases of diarrhea (line) from which GARV-positive
cases were identified.
and in contrast to those elsewhere in Africa. Similar to Africa
in general and Kenya specifically, we found a predominance of
genotype combinations G1, G8, and G9, with P[4], P[6], and
P[8] [7, 11]. The G-P combinations found in 190% of isolates
in temperate countries in Europe and North America and in
parts of Australia and Oceania were identified at a proportion
of only 68%, consistent with the African context [7]. However,
the prevalence of P[8]G1 (42%) and P[8]G9 (15%) was un-
usually high, there was an absence of 2 usually frequent ge-
notypes (P[8]G3 and P[8]G4), and no case of the emergent
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Figure 3. Distribution of genotype frequencies by month during 2002
(A), 2003 (B), and 2004 (C) among 558 rotavirus-positive patients admitted
to Kilifi District Hospital, Kenya.
G12 type was identified. Genotypes recognized as unusual
worldwide [7], in particular, G8 variants (P[4]G8, P[8]G8, and
P[6]G8), comprised 25% of all single strains (Table 2), and the
prevalence of mixed G-P combinations was 10%; both pro-
portions were similar to that in Africa overall [7].
Furthermore, we observed significant temporal variation in
the prevalence of some genotypes. Although P[8]G1 was the
predominant variant overall, its prevalence decreased markedly
from ∼50% during 2002–2003 to 30% during 2004. By contrast,
the prevalence of P[4]G8 increased from 2%–4% during 2002–
2003 to 13% during 2004, and the prevalences of both P[6]G8
and P[8]G8 were moderate during 2002 and 2004 and were
almost absent during 2003. Of further interest, mixed genotypes
showed a significant increase between 2002 and 2003–2004.
Temporal variation of this nature has been observed previously
[33]. Kenya, for example, has seen the emergence of G8 and
G9 and a shift in predominance of P[8] to P[6], accompanied
by considerable year-to-year variation [34]. However, our data
show local patterns inconsistent with the national picture; for
example, P[8] remains the predominant P type in Kilifi for all
years studied. All these studies show the limitation of short-
term surveillance in discerning patterns of prevalence; however,
in addition, our results show the importance of widespread
monitoring to capture local variation, which may be of im-
portance in assessing vaccine impact.
Rotavirus hospitalizations are often observed to have marked
seasonality, particularly in developed countries. In Kilifi, we
observed peak group A rotavirus admissions from March
through May during 2002–2003, with a higher prevalence dur-
ing 2004, particularly during the third quarter, all of which
mirrored total diarrhea admissions over this period (Figure 2)
[20]. A greater proportional representation of a wide group of
variants occurred during 2004 (Figure 2), with the emergence
of P[4]G8 early in 2004 associated with a delay in the peak in
P[8]G1 to the third quarter. Clearly, longer-term surveillance
has the capacity to identify genotype emergence, decay, and
altering dominance patterns, which have a bearing on potential
vaccine effectiveness and the value of before–and-after studies
in assessing vaccine impact.
The diversity of group A rotavirus types identified in Kilifi
is supplemented by a high proportion of unusual G-P com-
binations, among which are likely reassortant strains. These
include rare occurrences of P[4]G9 and P[8]G2 and emergence
of P[4]G1, all probable human-human reassortants. The pres-
ence, among isolates of mixed G-P type, of strains inclusive of
these unusual and emergent combinations (eg P[4]G1,8;
P[4]G8,9; P[6,8]G1,8; P[6,8]G2,3,8; P[8]G1,8; and P[8]G8,9)
provides strong circumstantial evidence for natural reassortant
events arising from cocirculating local strains. The prevalence
of 9% of strains untypeable for at least one of VP4 or VP7
genes, presumably a result of antigenic drift, provides further
evidence for extensive natural variation in rotavirus strains in
this location.
Esona et al [35] recently investigated the characteristics of
all 11 genes of G8 rotavirus strains detected in Cote d’ Ivoire,
Cameroon, Ethiopia, and Tunisia. The study found that genes
for VP7, NSP2, and NSP5 were closely related to cognate genes
of animal strains and suggested that African G8 strains may
have arisen through reassortment of VP7 and VP4 genes. In
our study, large numbers of P[4]G8 (emerging in 2004) and
P[6]G8 and P[8]G8 (showing marked year-to-year variation)
were detected. Furthermore, G10, P[11], and P[14] genotypes,
more commonly associated with infections in animals, were
detected in mixed infections. Although additional analysis of
the full genomes of these strains will be required, the possibility
exists that these strains are human-animal reassortants and may
provide evidence of animal rotaviruses acting as reservoirs for
one or several genes of human rotavirus strains.
Severe rotavirus disease represents a major burden in de-
veloping countries and is an identified target for vaccine in-
tervention [36]. Antigenic diversity of strains in cocirculation,
antigenic drift, and emergence of new variants through reas-
sortment (human with human and human with animal) and
animal introductions [33] represent considerable potential for
impaired vaccine efficacy. Our study provides support for the
presence of each of these elements of variation in Kilifi, which,
together with evidence of geographical and temporal variation
in prevalent genotype composition, have a bearing on potential
vaccine effectiveness and on the potential to measure vaccine
impact through surveillance.
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